These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6243570)

  • 1. Transformation is an alternative to normal skeletal muscle development.
    Kaufman SJ; Parks CM; Bohn J; Faiman LE
    Exp Cell Res; 1980 Feb; 125(2):333-49. PubMed ID: 6243570
    [No Abstract]   [Full Text] [Related]  

  • 2. Parameters distinguishing herpes simplex virus type 2-transformed tumorigenic and nontumorigenic rat cells.
    Hale AH; Kucera LS; Daniel LW; Waite M
    Cancer Res; 1981 Feb; 41(2):629-34. PubMed ID: 6256070
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of correlation between loss of anchorage-independent growth and levels of transformation-specific p53 protein in retinoic acid-treated F9 embryonal carcinoma cells.
    Rodrigues M; Balicki D; Newrock KM; Mukherjee BB
    Exp Cell Res; 1985 Jan; 156(1):22-30. PubMed ID: 2981174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of polypeptide synthesis in myoblast hybrids.
    Brzeski H; Linder S; Krondahl U; Ringertz NR
    Exp Cell Res; 1980 Aug; 128(2):267-78. PubMed ID: 7408992
    [No Abstract]   [Full Text] [Related]  

  • 5. Rous-sarcoma-virus-transformed fibroblasts having low levels of plasminogen activator.
    Wolf BA; Goldberg AR
    Proc Natl Acad Sci U S A; 1976 Oct; 73(10):3613-7. PubMed ID: 185621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activators and their inhibitors in the neuromuscular system: I. Developmental regulation of plasminogen activator isoforms during in vitro myogenesis in two cell lines.
    Festoff BW; Rao JS; Maben C; Hantaï D
    J Cell Physiol; 1990 Aug; 144(2):262-71. PubMed ID: 2199466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human carcinoembryonic antigen, an intercellular adhesion molecule, blocks fusion and differentiation of rat myoblasts.
    Eidelman FJ; Fuks A; DeMarte L; Taheri M; Stanners CP
    J Cell Biol; 1993 Oct; 123(2):467-75. PubMed ID: 8408226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synergistic effect of glucocorticoids and insulin on the differentiation of myoblasts.
    Ball EH; Sanwal BD
    J Cell Physiol; 1980 Jan; 102(1):27-36. PubMed ID: 6246123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and chromosomal alterations in cell cultures as indicators of tumor-promoting activity.
    Fusenig NE; Dzarlieva RT
    Carcinog Compr Surv; 1982; 7():201-16. PubMed ID: 7039829
    [No Abstract]   [Full Text] [Related]  

  • 10. The correlation between plasminogen activator-stimulated DNA synthesis and cell morphology in 3T3 cells.
    Urquhart C; Whur P; Gordon M; Silcox JJ; Williams DC; Wright ED
    Exp Cell Res; 1978 Apr; 113(1):31-8. PubMed ID: 639871
    [No Abstract]   [Full Text] [Related]  

  • 11. [2 malignant cell lines derived from strain L6 of rat myogenic cells].
    Hillion J; Leibovitch MP; Leibovitch SA; Harel J
    Bull Cancer; 1982; 69(5):413-9. PubMed ID: 6187400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the transformed phenotype of hepatoma cells after hybridization with normal diploid fibroblasts.
    Szpirer C; Szpirer J
    Exp Cell Res; 1980 Feb; 125(2):305-12. PubMed ID: 7353597
    [No Abstract]   [Full Text] [Related]  

  • 13. Transformation by myc prevents fusion but not biochemical differentiation of C2C12 myoblasts: mechanisms of phenotypic correction in mixed culture with normal cells.
    Crescenzi M; Crouch DH; Tatò F
    J Cell Biol; 1994 Jun; 125(5):1137-45. PubMed ID: 8195295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibronectin delays the fusion of L6 myoblasts.
    Podleski TR; Greenberg I; Schlessinger J; Yamada KM
    Exp Cell Res; 1979 Sep; 122(2):317-26. PubMed ID: 510407
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of urokinase-type plasminogen activator (uPA) abrogates myogenesis in vitro.
    Muñoz-Cánoves P; Miralles F; Baiget M; Félez J
    Thromb Haemost; 1997 Mar; 77(3):526-34. PubMed ID: 9066006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator in chick embryo muscle cells: induction of enzyme by RSV, PMA and retinoic acid.
    Miskin R; Easton TG; Reich E
    Cell; 1978 Dec; 15(4):1301-12. PubMed ID: 215322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cell hybrids: analysis of transformation and tumorigenicity.
    Stanbridge EJ; Der CJ; Doersen CJ; Nishimi RY; Peehl DM; Weissman BE; Wilkinson JE
    Science; 1982 Jan; 215(4530):252-9. PubMed ID: 7053574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different biological targets for resiniferatoxin and phorbol 12-myristate 13-acetate.
    Driedger PE; Blumberg PM
    Cancer Res; 1980 May; 40(5):1400-4. PubMed ID: 7189445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular plasminogen activator activity in growing and quiescent cells.
    Loskutoff DJ; Paul D
    J Cell Physiol; 1978 Oct; 97(1):9-16. PubMed ID: 213444
    [No Abstract]   [Full Text] [Related]  

  • 20. The transformation process.
    Laerum OD; Mørk SJ; De Ridder L
    Prog Exp Tumor Res; 1984; 27():17-31. PubMed ID: 6385124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.